The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and in humans.
about
Quinupristin-dalfopristin is active against Toxoplasma gondiiIn vitro and in vivo effects of quinupristin-dalfopristin against Pneumocystis cariniiPharmacokinetics and safety of recently approved drugs used to treat methicillin-resistant Staphylococcus aureus infections in infants, children and adults.Pharmacodynamic analysis of the activity of quinupristin-dalfopristin against vancomycin-resistant Enterococcus faecium with differing MBCs via time-kill-curve and postantibiotic effect methods.Treatment of vancomycin-resistant Enterococcus faecium with RP 59500 (quinupristin-dalfopristin) administered by intermittent or continuous infusion, alone or in combination with doxycycline, in an in vitro pharmacodynamic infection model with simulBactericidal activity of quinupristin-dalfopristin against Staphylococcus aureus: clindamycin susceptibility as a surrogate indicatorQuinupristin-dalfopristin: an overview.Hyperbilirubinemia during quinupristin-dalfopristin therapy in liver transplant recipients: correlation with available liver biopsy results.Gram-positive resistance: pathogens, implications, and treatment options: insights from the Society of Infectious Diseases Pharmacists.Current use of anti-infectives in dermatology.Pharmacologic options for CNS infections caused by resistant Gram-positive organisms.Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom.Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesin expression in biofilm-forming Staphylococcus epidermidis.Postantibiotic effect and postantibiotic sub-MIC effect of quinupristin-dalfopristin against gram-positive and -negative organisms.Quinupristin/dalfopristin: the first available macrolide-lincosamide-streptogramin antibiotic.Streptogramin-based gene regulation systems for mammalian cells.Telithromycin and quinupristin-dalfopristin induce delayed death in Plasmodium falciparum.Multiple-dose pharmacokinetics and safety of two regimens of quinupristin/dalfopristin (Synercid) in healthy volunteers.Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristin.
P2860
Q28343473-7D158EC8-B913-4E96-99DF-B3FFC87E7176Q28361588-987C48DF-34B7-467F-A272-90C0406386F4Q33657212-7F6FF2F8-1D19-47FE-9755-12034D56799BQ33695596-0543A58C-DC74-43BE-9258-E5D64C3AE396Q33700022-16EED9DE-87FF-4C56-B36F-3D47B39C5DEDQ33980853-1E6164AA-F83D-4825-BB25-47DF491B8086Q34113774-549473C7-E139-416E-946D-A596303F870DQ34278834-3CFA42E9-997B-4E28-BD25-78673766A2F8Q36188333-7BEE5448-6B32-4C7A-9614-BC0312844659Q36233506-CBE41CF0-B6FA-4637-A84B-E35C8EBF2D65Q37077629-78740C92-2798-4610-B362-45EFDB69B854Q37413851-154F6CBD-6D93-468D-898E-1976BAFE3C2CQ39475687-9245351A-8570-44FA-83EE-539DCA114149Q39559533-34011DDB-CA68-46D9-A671-10EE5D0E8F47Q40561137-CCCD0A39-9CD3-4724-9AEA-0F59899E58E3Q40844545-645C8D4B-2E77-4885-977E-E6F0C8EF1646Q41915221-03EF42CD-4039-4877-A444-07F0ACB7454CQ42647517-539DD041-7D38-48FB-ACA1-911DDB250A3BQ43773396-B86CA67A-65B7-434D-B4EA-3133B8D2DFD1
P2860
The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and in humans.
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and in humans.
@ast
The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and in humans.
@en
The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and in humans.
@nl
type
label
The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and in humans.
@ast
The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and in humans.
@en
The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and in humans.
@nl
prefLabel
The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and in humans.
@ast
The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and in humans.
@en
The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and in humans.
@nl
P356
P1476
The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and in humans.
@en
P2093
P304
P356
10.1093/JAC/39.SUPPL_1.129
P407
P478
39 Suppl A
P577
1997-05-01T00:00:00Z